Citadel Advisors’s CytRx Corp CYTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-34,569
| Closed | -$21.7K | – | 10384 |
|
|
2018
Q4 | $16K | Buy |
34,569
+4,477
| +15% | +$3.09K | ﹤0.01% | 8833 |
|
|
2018
Q3 | $32K | Buy |
+30,092
| New | +$34K | ﹤0.01% | 8916 |
|
|
2018
Q1 | – | Sell |
-20,118
| Closed | -$35.4K | – | 9238 |
|
|
2017
Q4 | $34K | Buy |
+20,118
| New | +$41.6K | ﹤0.01% | 7744 |
|
|
2017
Q2 | – | Sell |
-2,121
| Closed | -$7.25K | – | 8598 |
|
|
2017
Q1 | $6K | Buy |
+2,121
| New | +$5.37K | ﹤0.01% | 7354 |
|
|
2016
Q4 | – | Sell |
-2,453
| Closed | -$7.21K | – | 8375 |
|
|
2016
Q3 | $9K | Buy |
+2,453
| New | +$11.2K | ﹤0.01% | 7150 |
|
|
2016
Q2 | – | Sell |
-3,678
| Closed | -$61.2K | – | 7962 |
|
|
2016
Q1 | $59K | Sell |
3,678
-10,469
| -74% | -$143K | ﹤0.01% | 6215 |
|
|
2015
Q4 | $225K | Buy |
+14,147
| New | +$243K | ﹤0.01% | 5658 |
|
|
2015
Q2 | – | Sell |
-8,038
| Closed | -$201K | – | 9500 |
|
|
2015
Q1 | $163K | Buy |
8,038
+1,098
| +16% | +$20.4K | ﹤0.01% | 6402 |
|
|
2014
Q4 | $114K | Sell |
6,940
-2,767
| -29% | -$43.2K | ﹤0.01% | 6538 |
|
|
2014
Q3 | $148K | Buy |
9,707
+3,984
| +70% | +$78.7K | ﹤0.01% | 6040 |
|
|
2014
Q2 | $144K | Buy |
+5,723
| New | +$130K | ﹤0.01% | 5904 |
|
|
2014
Q1 | – | Sell |
-1,347
| Closed | -$51K | – | 8327 |
|
|
2013
Q4 | $51K | Buy |
+1,347
| New | +$24.5K | ﹤0.01% | 6033 |
|
|
2013
Q3 | – | Sell |
-1,831
| Closed | -$22K | – | 7152 |
|
|
2013
Q2 | $22K | Buy |
+1,831
| New | +$27K | ﹤0.01% | 6041 |
|
Other funds holding CYTR
Citadel Advisors's CYTR Position: Q1 2019 in Review
Citadel Advisors sold out of CytRx Corp (CYTR) in Q1 2019, closing a stake of 34,569 shares — an estimated $21.7K sold.
Citadel Advisors first reported a position in CYTR in Q2 2013 and held it in 13 quarters. The position peaked at $225K in Q4 2015. 35 funds tracked by Wall St. Rank hold CYTR as of Q1 2019.
- Citadel Advisors reported no remaining CytRx Corp position as of Q1 2019 after selling out during the quarter.
- Citadel Advisors sold 34,569 CytRx Corp shares in Q1 2019, an estimated $21.7K.
- Citadel Advisors first reported a position in CytRx Corp in Q2 2013 and held it in 13 quarters.
- Citadel Advisors's CytRx Corp position peaked at $225K in Q4 2015.
- 35 funds tracked by Wall St. Rank held CytRx Corp as of Q1 2019.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.